カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界の胃がん治療市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Gastric Cancer Therapy Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19343）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19343
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：121
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の胃がん治療市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

胃がん治療市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の胃がん治療の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

胃がん治療市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・処方薬、一般用医薬品

用途別セグメントは次のように区分されます。
・オンライン販売、オフライン販売

世界の胃がん治療市場の主要な市場プレーヤーは以下のとおりです。
・Novartis AG、Glaxo SmithKline Plc、Roche Holding Limited、AptarGroup Incorporated、Squibb Company、Boston Scientific Corporation、Pfizer.、Agilent Technologies, Inc.、Illumina, Inc.、Thermo Fisher Scientific, Inc.、General Electric Company、BD、Abbott、QIAGEN、Siemens Healthcare GmbH、F. Hoffmann-La Roche Ltd.、Koninklijke Philips N.V.、Eli Lilly and Company、F. Hoffmann-La Roche Ltd.、Merck KGaA

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、胃がん治療製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な胃がん治療メーカーの企業概要、2019年～2022年までの胃がん治療の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な胃がん治療メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別胃がん治療の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの胃がん治療の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での胃がん治療市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および胃がん治療の産業チェーンを掲載しています。
・第13、14、15章では、胃がん治療の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 胃がん治療の概要
- 種類別分析（2017年vs2021年vs2028年）：処方薬、一般用医薬品
- 用途別分析（2017年vs2021年vs2028年）：オンライン販売、オフライン販売
- 世界の胃がん治療市場規模・予測
- 世界の胃がん治療生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Novartis AG、Glaxo SmithKline Plc、Roche Holding Limited、AptarGroup Incorporated、Squibb Company、Boston Scientific Corporation、Pfizer.、Agilent Technologies, Inc.、Illumina, Inc.、Thermo Fisher Scientific, Inc.、General Electric Company、BD、Abbott、QIAGEN、Siemens Healthcare GmbH、F. Hoffmann-La Roche Ltd.、Koninklijke Philips N.V.、Eli Lilly and Company、F. Hoffmann-La Roche Ltd.、Merck KGaA
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：処方薬、一般用医薬品
・用途別分析2017年-2028年：オンライン販売、オフライン販売
・胃がん治療の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・胃がん治療のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・胃がん治療のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・胃がん治療の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・胃がん治療の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Gastric Cancer Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Gastric Cancer Therapy market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Online Sales accounting for % of the Gastric Cancer Therapy global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Prescription Drugs segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Gastric Cancer Therapy include Novartis AG, Glaxo SmithKline Plc, Roche Holding Limited, AptarGroup Incorporated, and Squibb Company, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Gastric Cancer Therapy market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Prescription Drugs
Non-Prescription Drugs
Market segment by Application can be divided into
Online Sales
Offline Sales
The key market players for global Gastric Cancer Therapy market are listed below:
Novartis AG
Glaxo SmithKline Plc
Roche Holding Limited
AptarGroup Incorporated
Squibb Company
Boston Scientific Corporation
Pfizer.
Agilent Technologies, Inc.
Illumina, Inc.
Thermo Fisher Scientific, Inc.
General Electric Company
BD
Abbott
QIAGEN
Siemens Healthcare GmbH
F. Hoffmann-La Roche Ltd.
Koninklijke Philips N.V.
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
Merck KGaA
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Gastric Cancer Therapy product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Gastric Cancer Therapy, with price, sales, revenue and global market share of Gastric Cancer Therapy from 2019 to 2022.
Chapter 3, the Gastric Cancer Therapy competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Gastric Cancer Therapy breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Gastric Cancer Therapy market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Gastric Cancer Therapy.
Chapter 13, 14, and 15, to describe Gastric Cancer Therapy sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Gastric Cancer Therapy Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Gastric Cancer Therapy Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Prescription Drugs
1.2.3 Non-Prescription Drugs
1.3 Market Analysis by Application
1.3.1 Overview: Global Gastric Cancer Therapy Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Online Sales
1.3.3 Offline Sales
1.4 Global Gastric Cancer Therapy Market Size & Forecast
1.4.1 Global Gastric Cancer Therapy Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Gastric Cancer Therapy Sales in Volume (2017-2028)
1.4.3 Global Gastric Cancer Therapy Price (2017-2028)
1.5 Global Gastric Cancer Therapy Production Capacity Analysis
1.5.1 Global Gastric Cancer Therapy Total Production Capacity (2017-2028)
1.5.2 Global Gastric Cancer Therapy Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Gastric Cancer Therapy Market Drivers
1.6.2 Gastric Cancer Therapy Market Restraints
1.6.3 Gastric Cancer Therapy Trends Analysis
2 Manufacturers Profiles
2.1 Novartis AG
2.1.1 Novartis AG Details
2.1.2 Novartis AG Major Business
2.1.3 Novartis AG Gastric Cancer Therapy Product and Services
2.1.4 Novartis AG Gastric Cancer Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Glaxo SmithKline Plc
2.2.1 Glaxo SmithKline Plc Details
2.2.2 Glaxo SmithKline Plc Major Business
2.2.3 Glaxo SmithKline Plc Gastric Cancer Therapy Product and Services
2.2.4 Glaxo SmithKline Plc Gastric Cancer Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Roche Holding Limited
2.3.1 Roche Holding Limited Details
2.3.2 Roche Holding Limited Major Business
2.3.3 Roche Holding Limited Gastric Cancer Therapy Product and Services
2.3.4 Roche Holding Limited Gastric Cancer Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 AptarGroup Incorporated
2.4.1 AptarGroup Incorporated Details
2.4.2 AptarGroup Incorporated Major Business
2.4.3 AptarGroup Incorporated Gastric Cancer Therapy Product and Services
2.4.4 AptarGroup Incorporated Gastric Cancer Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Squibb Company
2.5.1 Squibb Company Details
2.5.2 Squibb Company Major Business
2.5.3 Squibb Company Gastric Cancer Therapy Product and Services
2.5.4 Squibb Company Gastric Cancer Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Boston Scientific Corporation
2.6.1 Boston Scientific Corporation Details
2.6.2 Boston Scientific Corporation Major Business
2.6.3 Boston Scientific Corporation Gastric Cancer Therapy Product and Services
2.6.4 Boston Scientific Corporation Gastric Cancer Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Pfizer.
2.7.1 Pfizer. Details
2.7.2 Pfizer. Major Business
2.7.3 Pfizer. Gastric Cancer Therapy Product and Services
2.7.4 Pfizer. Gastric Cancer Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Agilent Technologies, Inc.
2.8.1 Agilent Technologies, Inc. Details
2.8.2 Agilent Technologies, Inc. Major Business
2.8.3 Agilent Technologies, Inc. Gastric Cancer Therapy Product and Services
2.8.4 Agilent Technologies, Inc. Gastric Cancer Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Illumina, Inc.
2.9.1 Illumina, Inc. Details
2.9.2 Illumina, Inc. Major Business
2.9.3 Illumina, Inc. Gastric Cancer Therapy Product and Services
2.9.4 Illumina, Inc. Gastric Cancer Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Thermo Fisher Scientific, Inc.
2.10.1 Thermo Fisher Scientific, Inc. Details
2.10.2 Thermo Fisher Scientific, Inc. Major Business
2.10.3 Thermo Fisher Scientific, Inc. Gastric Cancer Therapy Product and Services
2.10.4 Thermo Fisher Scientific, Inc. Gastric Cancer Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 General Electric Company
2.11.1 General Electric Company Details
2.11.2 General Electric Company Major Business
2.11.3 General Electric Company Gastric Cancer Therapy Product and Services
2.11.4 General Electric Company Gastric Cancer Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 BD
2.12.1 BD Details
2.12.2 BD Major Business
2.12.3 BD Gastric Cancer Therapy Product and Services
2.12.4 BD Gastric Cancer Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Abbott
2.13.1 Abbott Details
2.13.2 Abbott Major Business
2.13.3 Abbott Gastric Cancer Therapy Product and Services
2.13.4 Abbott Gastric Cancer Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 QIAGEN
2.14.1 QIAGEN Details
2.14.2 QIAGEN Major Business
2.14.3 QIAGEN Gastric Cancer Therapy Product and Services
2.14.4 QIAGEN Gastric Cancer Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Siemens Healthcare GmbH
2.15.1 Siemens Healthcare GmbH Details
2.15.2 Siemens Healthcare GmbH Major Business
2.15.3 Siemens Healthcare GmbH Gastric Cancer Therapy Product and Services
2.15.4 Siemens Healthcare GmbH Gastric Cancer Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 F. Hoffmann-La Roche Ltd.
2.16.1 F. Hoffmann-La Roche Ltd. Details
2.16.2 F. Hoffmann-La Roche Ltd. Major Business
2.16.3 F. Hoffmann-La Roche Ltd. Gastric Cancer Therapy Product and Services
2.16.4 F. Hoffmann-La Roche Ltd. Gastric Cancer Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17 Koninklijke Philips N.V.
2.17.1 Koninklijke Philips N.V. Details
2.17.2 Koninklijke Philips N.V. Major Business
2.17.3 Koninklijke Philips N.V. Gastric Cancer Therapy Product and Services
2.17.4 Koninklijke Philips N.V. Gastric Cancer Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18 Eli Lilly and Company
2.18.1 Eli Lilly and Company Details
2.18.2 Eli Lilly and Company Major Business
2.18.3 Eli Lilly and Company Gastric Cancer Therapy Product and Services
2.18.4 Eli Lilly and Company Gastric Cancer Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.19 F. Hoffmann-La Roche Ltd.
2.19.1 F. Hoffmann-La Roche Ltd. Details
2.19.2 F. Hoffmann-La Roche Ltd. Major Business
2.19.3 F. Hoffmann-La Roche Ltd. Gastric Cancer Therapy Product and Services
2.19.4 F. Hoffmann-La Roche Ltd. Gastric Cancer Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.20 Merck KGaA
2.20.1 Merck KGaA Details
2.20.2 Merck KGaA Major Business
2.20.3 Merck KGaA Gastric Cancer Therapy Product and Services
2.20.4 Merck KGaA Gastric Cancer Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Gastric Cancer Therapy Breakdown Data by Manufacturer
3.1 Global Gastric Cancer Therapy Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Gastric Cancer Therapy Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Gastric Cancer Therapy
3.4 Market Concentration Rate
3.4.1 Top 3 Gastric Cancer Therapy Manufacturer Market Share in 2021
3.4.2 Top 6 Gastric Cancer Therapy Manufacturer Market Share in 2021
3.5 Global Gastric Cancer Therapy Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Gastric Cancer Therapy Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Gastric Cancer Therapy Market Size by Region
4.1.1 Global Gastric Cancer Therapy Sales in Volume by Region (2017-2028)
4.1.2 Global Gastric Cancer Therapy Revenue by Region (2017-2028)
4.2 North America Gastric Cancer Therapy Revenue (2017-2028)
4.3 Europe Gastric Cancer Therapy Revenue (2017-2028)
4.4 Asia-Pacific Gastric Cancer Therapy Revenue (2017-2028)
4.5 South America Gastric Cancer Therapy Revenue (2017-2028)
4.6 Middle East and Africa Gastric Cancer Therapy Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Gastric Cancer Therapy Sales in Volume by Type (2017-2028)
5.2 Global Gastric Cancer Therapy Revenue by Type (2017-2028)
5.3 Global Gastric Cancer Therapy Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Gastric Cancer Therapy Sales in Volume by Application (2017-2028)
6.2 Global Gastric Cancer Therapy Revenue by Application (2017-2028)
6.3 Global Gastric Cancer Therapy Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Gastric Cancer Therapy Sales by Type (2017-2028)
7.2 North America Gastric Cancer Therapy Sales by Application (2017-2028)
7.3 North America Gastric Cancer Therapy Market Size by Country
7.3.1 North America Gastric Cancer Therapy Sales in Volume by Country (2017-2028)
7.3.2 North America Gastric Cancer Therapy Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Gastric Cancer Therapy Sales by Type (2017-2028)
8.2 Europe Gastric Cancer Therapy Sales by Application (2017-2028)
8.3 Europe Gastric Cancer Therapy Market Size by Country
8.3.1 Europe Gastric Cancer Therapy Sales in Volume by Country (2017-2028)
8.3.2 Europe Gastric Cancer Therapy Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Gastric Cancer Therapy Sales by Type (2017-2028)
9.2 Asia-Pacific Gastric Cancer Therapy Sales by Application (2017-2028)
9.3 Asia-Pacific Gastric Cancer Therapy Market Size by Region
9.3.1 Asia-Pacific Gastric Cancer Therapy Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Gastric Cancer Therapy Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Gastric Cancer Therapy Sales by Type (2017-2028)
10.2 South America Gastric Cancer Therapy Sales by Application (2017-2028)
10.3 South America Gastric Cancer Therapy Market Size by Country
10.3.1 South America Gastric Cancer Therapy Sales in Volume by Country (2017-2028)
10.3.2 South America Gastric Cancer Therapy Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Gastric Cancer Therapy Sales by Type (2017-2028)
11.2 Middle East & Africa Gastric Cancer Therapy Sales by Application (2017-2028)
11.3 Middle East & Africa Gastric Cancer Therapy Market Size by Country
11.3.1 Middle East & Africa Gastric Cancer Therapy Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Gastric Cancer Therapy Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Gastric Cancer Therapy and Key Manufacturers
12.2 Manufacturing Costs Percentage of Gastric Cancer Therapy
12.3 Gastric Cancer Therapy Production Process
12.4 Gastric Cancer Therapy Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Gastric Cancer Therapy Typical Distributors
13.3 Gastric Cancer Therapy Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Gastric Cancer Therapy Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Gastric Cancer Therapy Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 4. Novartis AG Major Business
Table 5. Novartis AG Gastric Cancer Therapy Product and Services
Table 6. Novartis AG Gastric Cancer Therapy Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Glaxo SmithKline Plc Basic Information, Manufacturing Base and Competitors
Table 8. Glaxo SmithKline Plc Major Business
Table 9. Glaxo SmithKline Plc Gastric Cancer Therapy Product and Services
Table 10. Glaxo SmithKline Plc Gastric Cancer Therapy Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Roche Holding Limited Basic Information, Manufacturing Base and Competitors
Table 12. Roche Holding Limited Major Business
Table 13. Roche Holding Limited Gastric Cancer Therapy Product and Services
Table 14. Roche Holding Limited Gastric Cancer Therapy Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. AptarGroup Incorporated Basic Information, Manufacturing Base and Competitors
Table 16. AptarGroup Incorporated Major Business
Table 17. AptarGroup Incorporated Gastric Cancer Therapy Product and Services
Table 18. AptarGroup Incorporated Gastric Cancer Therapy Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Squibb Company Basic Information, Manufacturing Base and Competitors
Table 20. Squibb Company Major Business
Table 21. Squibb Company Gastric Cancer Therapy Product and Services
Table 22. Squibb Company Gastric Cancer Therapy Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Boston Scientific Corporation Basic Information, Manufacturing Base and Competitors
Table 24. Boston Scientific Corporation Major Business
Table 25. Boston Scientific Corporation Gastric Cancer Therapy Product and Services
Table 26. Boston Scientific Corporation Gastric Cancer Therapy Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Pfizer. Basic Information, Manufacturing Base and Competitors
Table 28. Pfizer. Major Business
Table 29. Pfizer. Gastric Cancer Therapy Product and Services
Table 30. Pfizer. Gastric Cancer Therapy Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Agilent Technologies, Inc. Basic Information, Manufacturing Base and Competitors
Table 32. Agilent Technologies, Inc. Major Business
Table 33. Agilent Technologies, Inc. Gastric Cancer Therapy Product and Services
Table 34. Agilent Technologies, Inc. Gastric Cancer Therapy Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Illumina, Inc. Basic Information, Manufacturing Base and Competitors
Table 36. Illumina, Inc. Major Business
Table 37. Illumina, Inc. Gastric Cancer Therapy Product and Services
Table 38. Illumina, Inc. Gastric Cancer Therapy Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Thermo Fisher Scientific, Inc. Basic Information, Manufacturing Base and Competitors
Table 40. Thermo Fisher Scientific, Inc. Major Business
Table 41. Thermo Fisher Scientific, Inc. Gastric Cancer Therapy Product and Services
Table 42. Thermo Fisher Scientific, Inc. Gastric Cancer Therapy Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. General Electric Company Basic Information, Manufacturing Base and Competitors
Table 44. General Electric Company Major Business
Table 45. General Electric Company Gastric Cancer Therapy Product and Services
Table 46. General Electric Company Gastric Cancer Therapy Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. BD Basic Information, Manufacturing Base and Competitors
Table 48. BD Major Business
Table 49. BD Gastric Cancer Therapy Product and Services
Table 50. BD Gastric Cancer Therapy Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Abbott Basic Information, Manufacturing Base and Competitors
Table 52. Abbott Major Business
Table 53. Abbott Gastric Cancer Therapy Product and Services
Table 54. Abbott Gastric Cancer Therapy Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. QIAGEN Basic Information, Manufacturing Base and Competitors
Table 56. QIAGEN Major Business
Table 57. QIAGEN Gastric Cancer Therapy Product and Services
Table 58. QIAGEN Gastric Cancer Therapy Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Siemens Healthcare GmbH Basic Information, Manufacturing Base and Competitors
Table 60. Siemens Healthcare GmbH Major Business
Table 61. Siemens Healthcare GmbH Gastric Cancer Therapy Product and Services
Table 62. Siemens Healthcare GmbH Gastric Cancer Therapy Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. F. Hoffmann-La Roche Ltd. Basic Information, Manufacturing Base and Competitors
Table 64. F. Hoffmann-La Roche Ltd. Major Business
Table 65. F. Hoffmann-La Roche Ltd. Gastric Cancer Therapy Product and Services
Table 66. F. Hoffmann-La Roche Ltd. Gastric Cancer Therapy Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 67. Koninklijke Philips N.V. Basic Information, Manufacturing Base and Competitors
Table 68. Koninklijke Philips N.V. Major Business
Table 69. Koninklijke Philips N.V. Gastric Cancer Therapy Product and Services
Table 70. Koninklijke Philips N.V. Gastric Cancer Therapy Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 71. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 72. Eli Lilly and Company Major Business
Table 73. Eli Lilly and Company Gastric Cancer Therapy Product and Services
Table 74. Eli Lilly and Company Gastric Cancer Therapy Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 75. F. Hoffmann-La Roche Ltd. Basic Information, Manufacturing Base and Competitors
Table 76. F. Hoffmann-La Roche Ltd. Major Business
Table 77. F. Hoffmann-La Roche Ltd. Gastric Cancer Therapy Product and Services
Table 78. F. Hoffmann-La Roche Ltd. Gastric Cancer Therapy Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 79. Merck KGaA Basic Information, Manufacturing Base and Competitors
Table 80. Merck KGaA Major Business
Table 81. Merck KGaA Gastric Cancer Therapy Product and Services
Table 82. Merck KGaA Gastric Cancer Therapy Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 83. Global Gastric Cancer Therapy Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 84. Global Gastric Cancer Therapy Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 85. Market Position of Manufacturers in Gastric Cancer Therapy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 86. Global Gastric Cancer Therapy Production Capacity by Company, (K Units): 2020 VS 2021
Table 87. Head Office and Gastric Cancer Therapy Production Site of Key Manufacturer
Table 88. Gastric Cancer Therapy New Entrant and Capacity Expansion Plans
Table 89. Gastric Cancer Therapy Mergers & Acquisitions in the Past Five Years
Table 90. Global Gastric Cancer Therapy Sales by Region (2017-2022) & (K Units)
Table 91. Global Gastric Cancer Therapy Sales by Region (2023-2028) & (K Units)
Table 92. Global Gastric Cancer Therapy Revenue by Region (2017-2022) & (USD Million)
Table 93. Global Gastric Cancer Therapy Revenue by Region (2023-2028) & (USD Million)
Table 94. Global Gastric Cancer Therapy Sales by Type (2017-2022) & (K Units)
Table 95. Global Gastric Cancer Therapy Sales by Type (2023-2028) & (K Units)
Table 96. Global Gastric Cancer Therapy Revenue by Type (2017-2022) & (USD Million)
Table 97. Global Gastric Cancer Therapy Revenue by Type (2023-2028) & (USD Million)
Table 98. Global Gastric Cancer Therapy Price by Type (2017-2022) & (US$/Unit)
Table 99. Global Gastric Cancer Therapy Price by Type (2023-2028) & (US$/Unit)
Table 100. Global Gastric Cancer Therapy Sales by Application (2017-2022) & (K Units)
Table 101. Global Gastric Cancer Therapy Sales by Application (2023-2028) & (K Units)
Table 102. Global Gastric Cancer Therapy Revenue by Application (2017-2022) & (USD Million)
Table 103. Global Gastric Cancer Therapy Revenue by Application (2023-2028) & (USD Million)
Table 104. Global Gastric Cancer Therapy Price by Application (2017-2022) & (US$/Unit)
Table 105. Global Gastric Cancer Therapy Price by Application (2023-2028) & (US$/Unit)
Table 106. North America Gastric Cancer Therapy Sales by Country (2017-2022) & (K Units)
Table 107. North America Gastric Cancer Therapy Sales by Country (2023-2028) & (K Units)
Table 108. North America Gastric Cancer Therapy Revenue by Country (2017-2022) & (USD Million)
Table 109. North America Gastric Cancer Therapy Revenue by Country (2023-2028) & (USD Million)
Table 110. North America Gastric Cancer Therapy Sales by Type (2017-2022) & (K Units)
Table 111. North America Gastric Cancer Therapy Sales by Type (2023-2028) & (K Units)
Table 112. North America Gastric Cancer Therapy Sales by Application (2017-2022) & (K Units)
Table 113. North America Gastric Cancer Therapy Sales by Application (2023-2028) & (K Units)
Table 114. Europe Gastric Cancer Therapy Sales by Country (2017-2022) & (K Units)
Table 115. Europe Gastric Cancer Therapy Sales by Country (2023-2028) & (K Units)
Table 116. Europe Gastric Cancer Therapy Revenue by Country (2017-2022) & (USD Million)
Table 117. Europe Gastric Cancer Therapy Revenue by Country (2023-2028) & (USD Million)
Table 118. Europe Gastric Cancer Therapy Sales by Type (2017-2022) & (K Units)
Table 119. Europe Gastric Cancer Therapy Sales by Type (2023-2028) & (K Units)
Table 120. Europe Gastric Cancer Therapy Sales by Application (2017-2022) & (K Units)
Table 121. Europe Gastric Cancer Therapy Sales by Application (2023-2028) & (K Units)
Table 122. Asia-Pacific Gastric Cancer Therapy Sales by Region (2017-2022) & (K Units)
Table 123. Asia-Pacific Gastric Cancer Therapy Sales by Region (2023-2028) & (K Units)
Table 124. Asia-Pacific Gastric Cancer Therapy Revenue by Region (2017-2022) & (USD Million)
Table 125. Asia-Pacific Gastric Cancer Therapy Revenue by Region (2023-2028) & (USD Million)
Table 126. Asia-Pacific Gastric Cancer Therapy Sales by Type (2017-2022) & (K Units)
Table 127. Asia-Pacific Gastric Cancer Therapy Sales by Type (2023-2028) & (K Units)
Table 128. Asia-Pacific Gastric Cancer Therapy Sales by Application (2017-2022) & (K Units)
Table 129. Asia-Pacific Gastric Cancer Therapy Sales by Application (2023-2028) & (K Units)
Table 130. South America Gastric Cancer Therapy Sales by Country (2017-2022) & (K Units)
Table 131. South America Gastric Cancer Therapy Sales by Country (2023-2028) & (K Units)
Table 132. South America Gastric Cancer Therapy Revenue by Country (2017-2022) & (USD Million)
Table 133. South America Gastric Cancer Therapy Revenue by Country (2023-2028) & (USD Million)
Table 134. South America Gastric Cancer Therapy Sales by Type (2017-2022) & (K Units)
Table 135. South America Gastric Cancer Therapy Sales by Type (2023-2028) & (K Units)
Table 136. South America Gastric Cancer Therapy Sales by Application (2017-2022) & (K Units)
Table 137. South America Gastric Cancer Therapy Sales by Application (2023-2028) & (K Units)
Table 138. Middle East & Africa Gastric Cancer Therapy Sales by Region (2017-2022) & (K Units)
Table 139. Middle East & Africa Gastric Cancer Therapy Sales by Region (2023-2028) & (K Units)
Table 140. Middle East & Africa Gastric Cancer Therapy Revenue by Region (2017-2022) & (USD Million)
Table 141. Middle East & Africa Gastric Cancer Therapy Revenue by Region (2023-2028) & (USD Million)
Table 142. Middle East & Africa Gastric Cancer Therapy Sales by Type (2017-2022) & (K Units)
Table 143. Middle East & Africa Gastric Cancer Therapy Sales by Type (2023-2028) & (K Units)
Table 144. Middle East & Africa Gastric Cancer Therapy Sales by Application (2017-2022) & (K Units)
Table 145. Middle East & Africa Gastric Cancer Therapy Sales by Application (2023-2028) & (K Units)
Table 146. Gastric Cancer Therapy Raw Material
Table 147. Key Manufacturers of Gastric Cancer Therapy Raw Materials
Table 148. Direct Channel Pros & Cons
Table 149. Indirect Channel Pros & Cons
Table 150. Gastric Cancer Therapy Typical Distributors
Table 151. Gastric Cancer Therapy Typical Customers
List of Figures
Figure 1. Gastric Cancer Therapy Picture
Figure 2. Global Gastric Cancer Therapy Revenue Market Share by Type in 2021
Figure 3. Prescription Drugs
Figure 4. Non-Prescription Drugs
Figure 5. Global Gastric Cancer Therapy Revenue Market Share by Application in 2021
Figure 6. Online Sales
Figure 7. Offline Sales
Figure 8. Global Gastric Cancer Therapy Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 9. Global Gastric Cancer Therapy Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Gastric Cancer Therapy Sales (2017-2028) & (K Units)
Figure 11. Global Gastric Cancer Therapy Price (2017-2028) & (US$/Unit)
Figure 12. Global Gastric Cancer Therapy Production Capacity (2017-2028) & (K Units)
Figure 13. Global Gastric Cancer Therapy Production Capacity by Geographic Region: 2022 VS 2028
Figure 14. Gastric Cancer Therapy Market Drivers
Figure 15. Gastric Cancer Therapy Market Restraints
Figure 16. Gastric Cancer Therapy Market Trends
Figure 17. Global Gastric Cancer Therapy Sales Market Share by Manufacturer in 2021
Figure 18. Global Gastric Cancer Therapy Revenue Market Share by Manufacturer in 2021
Figure 19. Gastric Cancer Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 20. Top 3 Gastric Cancer Therapy Manufacturer (Revenue) Market Share in 2021
Figure 21. Top 6 Gastric Cancer Therapy Manufacturer (Revenue) Market Share in 2021
Figure 22. Global Gastric Cancer Therapy Sales Market Share by Region (2017-2028)
Figure 23. Global Gastric Cancer Therapy Revenue Market Share by Region (2017-2028)
Figure 24. North America Gastric Cancer Therapy Revenue (2017-2028) & (USD Million)
Figure 25. Europe Gastric Cancer Therapy Revenue (2017-2028) & (USD Million)
Figure 26. Asia-Pacific Gastric Cancer Therapy Revenue (2017-2028) & (USD Million)
Figure 27. South America Gastric Cancer Therapy Revenue (2017-2028) & (USD Million)
Figure 28. Middle East & Africa Gastric Cancer Therapy Revenue (2017-2028) & (USD Million)
Figure 29. Global Gastric Cancer Therapy Sales Market Share by Type (2017-2028)
Figure 30. Global Gastric Cancer Therapy Revenue Market Share by Type (2017-2028)
Figure 31. Global Gastric Cancer Therapy Price by Type (2017-2028) & (US$/Unit)
Figure 32. Global Gastric Cancer Therapy Sales Market Share by Application (2017-2028)
Figure 33. Global Gastric Cancer Therapy Revenue Market Share by Application (2017-2028)
Figure 34. Global Gastric Cancer Therapy Price by Application (2017-2028) & (US$/Unit)
Figure 35. North America Gastric Cancer Therapy Sales Market Share by Type (2017-2028)
Figure 36. North America Gastric Cancer Therapy Sales Market Share by Application (2017-2028)
Figure 37. North America Gastric Cancer Therapy Sales Market Share by Country (2017-2028)
Figure 38. North America Gastric Cancer Therapy Revenue Market Share by Country (2017-2028)
Figure 39. United States Gastric Cancer Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 40. Canada Gastric Cancer Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Mexico Gastric Cancer Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Europe Gastric Cancer Therapy Sales Market Share by Type (2017-2028)
Figure 43. Europe Gastric Cancer Therapy Sales Market Share by Application (2017-2028)
Figure 44. Europe Gastric Cancer Therapy Sales Market Share by Country (2017-2028)
Figure 45. Europe Gastric Cancer Therapy Revenue Market Share by Country (2017-2028)
Figure 46. Germany Gastric Cancer Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. France Gastric Cancer Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. United Kingdom Gastric Cancer Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Russia Gastric Cancer Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Italy Gastric Cancer Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Asia-Pacific Gastric Cancer Therapy Sales Market Share by Region (2017-2028)
Figure 52. Asia-Pacific Gastric Cancer Therapy Sales Market Share by Application (2017-2028)
Figure 53. Asia-Pacific Gastric Cancer Therapy Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Gastric Cancer Therapy Revenue Market Share by Region (2017-2028)
Figure 55. China Gastric Cancer Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Japan Gastric Cancer Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Korea Gastric Cancer Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. India Gastric Cancer Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Southeast Asia Gastric Cancer Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Australia Gastric Cancer Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South America Gastric Cancer Therapy Sales Market Share by Type (2017-2028)
Figure 62. South America Gastric Cancer Therapy Sales Market Share by Application (2017-2028)
Figure 63. South America Gastric Cancer Therapy Sales Market Share by Country (2017-2028)
Figure 64. South America Gastric Cancer Therapy Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Gastric Cancer Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Gastric Cancer Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East & Africa Gastric Cancer Therapy Sales Market Share by Type (2017-2028)
Figure 68. Middle East & Africa Gastric Cancer Therapy Sales Market Share by Application (2017-2028)
Figure 69. Middle East & Africa Gastric Cancer Therapy Sales Market Share by Region (2017-2028)
Figure 70. Middle East & Africa Gastric Cancer Therapy Revenue Market Share by Region (2017-2028)
Figure 71. Turkey Gastric Cancer Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Egypt Gastric Cancer Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Gastric Cancer Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South Africa Gastric Cancer Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Manufacturing Cost Structure Analysis of Gastric Cancer Therapy in 2021
Figure 76. Manufacturing Process Analysis of Gastric Cancer Therapy
Figure 77. Gastric Cancer Therapy Industrial Chain
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 乳がん標的療法のグローバル市場展望 2023年-2029年：ブランド医薬品、ジェネリック医薬品
  • がん薬物治療のグローバル市場展望 2023年-2029年：標的治療、化学治療、免疫治療
  • 世界の胃潰瘍検出キット市場2022年：市場規模予測（～2028年）
  • 胃ポンプの世界市場2023年：使い捨て型、再利用型
  • 腹腔鏡下胃バイパス手術装置のグローバル市場展望 2023年-2029年：スリーブ型胃切除術装置、調節可能型胃バンド、垂直帯胃形成術装置、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19343 )"世界の胃がん治療市場2022年：市場規模予測（～2028年）" (英文：Global Gastric Cancer Therapy Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。